Trial intelligence / Profile preview

Levothyroxine for Subclinical Hypothyroidism After Head and Neck Surgery

NCT02548715Phase 3Withdrawn

Sponsor
University of Alberta
Start
Jul 2015
Primary completion
Jul 2017
Modality
Small Molecules
01

Overview

A Phase 3 trial of levothyroxine sodium in hypothyroidism, sponsored by University of Alberta. Planned start Jul 2015; status: withdrawn.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT02548715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02548715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call